AJP - Heart pressure measurements
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (July 15, 2005). doi:10.1152/ajpheart.00225.2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
289/6/H2392    most recent
00225.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Web of Science (11)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cabrales, P.
Right arrow Articles by Intaglietta, M.
Submitted on March 8, 2005
Accepted on July 11, 2005

EXTREME HEMODILUTION WITH PEG-HEMOGLOBIN VS. PEG-ALBUMIN

Pedro Cabrales1*, Amy G Tsai1, Robert M Winslow2, and Marcos Intaglietta1

1 La Jolla Bioengineering Institute, La Jolla, CA, USA; Bioengineering, University of California, San Diego, La Jolla, CA, USA
2 Sangart, Inc, San Diego, CA, USA; Bioengineering, University of California, San Diego, La Jolla, CA, USA

* To whom correspondence should be addressed. E-mail: pcabrales{at}ucsd.edu.

Isovolemic hemodilution to 11% systemic hematocrit (Hct) was performed in the hamster window chamber model, using 6% dextran 70 kDa (Dx 70) and 5% human serum albumin (HSA). Systemic and microvascular effects of these solutions were compared to polyethylene glycol (PEG) conjugated 5% albumin (MPA) and PEG-conjugated 4.2% hemoglobin (MP4). These studies were performed for the purpose of comparing systemic and microvascular responses of PEG vs. non-PEG plasma expanders, and similar oxygen carrying vs. non carrying blood replacement fluids. Mean arterial blood pressure (MAP) was statistically significantly reduced for all groups compared to baseline (P < 0.05), with HSA, MPA and MP4 higher than Dx 70 (P < 0.05). MP4 and MPA had a significantly higher cardiac index than HSA and Dx 70, in addition to a positive base excess. Microvascular blood flow and capillary perfusion were significantly higher for the PEG compounds compared with HSA and Dx 70. Intravascular pO2 for MP4 and MPA was higher in arterioles (P < 0.05) when compared to HSA and Dx 70, but there was no difference in either tissue or venular pO2 between groups. Total hemoglobin (Hb) in the MP4 group was 4.8 ± 0.4 g/dl, while the remaining groups had a range of 3.6 - 3.8 g/dl. The hemodilution results showed that PEG compounds maintained microvascular conditions with lower concentrations than conventional plasma expanders. Furthermore, microvascular oxygen delivery and extraction in the window chamber tissue were significantly higher for the PEG compounds. MP4 was significantly higher than MPA (P < 0.05) and was not statistically different from baseline, an effect due to the additional oxygen release to the tissue by the Hb MP4.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.